Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13913975 | 0.79 | NOTUM (0.46) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL6688356 | 0.79 | NOTUM (0.46) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL7039122 | 0.79 | NOTUM (0.46) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL12849442 | 0.79 | NOTUM (0.46) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL15962082 | 0.75 | SELL (0.42) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL7042089 | 0.75 | DRD2 (0.42) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL1702274 | 0.75 | NOTUM (0.42) | NOTUMDRD2DRD4 | |
| SCHEMBL30537817 | 0.74 | PARP1 (0.56) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL93672 | 0.74 | PARP1 (0.56) | ACHENOTUMDRD2DRD4PARP1 | |
| SCHEMBL9195736 | 0.74 | ACHE (0.66) | ACHEPARP1ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582351-B1 | HAIR DYEING PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE INDOLE OR INDOLINE COMPOUND, A METAL SALT, HYDROGEN PEROXIDE AND A BASIFYING AGENT | L'ORÉAL (FR) | 2017-08-02 | — | — | EP | claimed |
| EP-2623093-B1 | DYE FOR KERATIN FIBERS USING BILIRUBIN OXIDASE AND INDOLE DERIVATIVES | AMANO ENZYME INC (JP) | 2016-05-25 | — | — | EP | claimed |
| US-20140359950-A1 | DYEING OF KERATIN FIBERS USING INDOLE ANALOGUE | AMANO ENZYME INC. (JP) | 2014-12-11 | — | — | US | claimed |
| US-8597373-B2 | Hair dyeing process using a composition comprising at least one indole or indoline compound, a metal salt, hydrogen peroxide and a basifying agent | L'OREAL (FR) | 2013-12-03 | — | — | US | claimed |
| US-20130174864-A1 | HAIR DYEING PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE INDOLE OR INDOLINE COMPOUND, A METAL SALT, HYDROGEN PEROXIDE AND A BASIFYING AGENT | L'OREAL (FR) | 2013-07-11 | — | — | US | claimed |
| EP-2582351-A1 | HAIR DYEING PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE INDOLE OR INDOLINE COMPOUND, A METAL SALT, HYDROGEN PEROXIDE AND A BASIFYING AGENT | L'Oréal (FR) | 2013-04-24 | — | — | EP | claimed |
| WO-2011157668-A1 | HAIR DYEING PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE INDOLE OR INDOLINE COMPOUND, A METAL SALT, HYDROGEN PEROXIDE AND A BASIFYING AGENT | L'OREAL (FR) | 2011-12-22 | — | — | WO | claimed |
| EP-0645999-B2 | METHOD FOR DYEING KERATIN FIBRES WITH INDOLE OR INDOLIN DERIVATIVES, HYDROGEN PEROXIDE AND A PEROXIDASE | OREAL (FR) | 2006-09-27 | — | — | EP | claimed |
| EP-0575604-B2 | INDOLINE PRODUCTS, METHODS FOR PREPARING SAME, AND USE THEREOF IN COSMETICS | OREAL (FR) | 2003-03-26 | — | — | EP | claimed |
| US-5776497-A | OXIDATIVE POLYMERIZATION OF INDOLINE FOR COSMETICS | L'OREAL (FR) | 1998-07-07 | — | — | US | claimed |
| EP-0645999-B1 | METHOD FOR DYEING KERATIN FIBRES WITH INDOLE OR INDOLIN DERIVATIVES, HYDROGEN PEROXIDE AND A PEROXIDASE | OREAL (FR) | 1996-01-31 | — | — | EP | claimed |
| EP-0575604-B1 | INDOLINE PRODUCTS, METHODS FOR PREPARING SAME, AND USE THEREOF IN COSMETICS | OREAL (FR) | 1995-12-06 | — | — | EP | claimed |
| EP-0603322-A1 | DYEING COMPOSITION BASED ON HYDROXYINDOLINE DERIVATIVES. | OREAL (FR) | 1994-06-29 | — | — | EP | claimed |
| EP-0575604-A1 | INDOLINE PRODUCTS, METHODS FOR PREPARING SAME, AND USE THEREOF IN COSMETICS. | OREAL (FR) | 1993-12-29 | — | — | EP | claimed |
| EP-0575605-A1 | MINERAL OR ORGANIC PARTICLE BASED PRODUCT COMPRISING AN INDOLINE PRODUCT. | OREAL (FR) | 1993-12-29 | — | — | EP | claimed |
| WO-1993013745-A1 | MINERAL OR ORGANIC PARTICLE BASED PRODUCT COMPRISING AN INDOLINE PRODUCT | L'OREAL (FR) | 1993-07-22 | — | — | WO | claimed |
| WO-1993013744-A1 | INDOLINE PRODUCTS, METHODS FOR PREPARING SAME, AND USE THEREOF IN COSMETICS | L'OREAL (FR) | 1993-07-22 | — | — | WO | claimed |
| EP-0544874-A1 | METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS | L'OREAL (FR) | 1993-06-09 | — | — | EP | claimed |
| WO-1993005018-A1 | DYEING COMPOSITION BASED ON HYDROXYINDOLINE DERIVATIVES | L'OREAL (FR) | 1993-03-18 | — | — | WO | claimed |
| WO-1993000068-A1 | METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS | L'OREAL (FR) | 1993-01-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130174864-A1 | HAIR DYEING PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE INDOLE OR INDOLINE COMPOUND, A METAL SALT, HYDROGEN PEROXIDE AND A BASIFYING AGENT | KRT18, HCN4, IDO1 | ACHE 512/4885NOTUM 2216/4885DRD2 969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.